CHROMAGEN ULTRA Trademark
Trademark Overview
On Thursday, February 13, 2003, a trademark application was filed for CHROMAGEN ULTRA with the United States Patent and Trademark Office. The USPTO has given the CHROMAGEN ULTRA trademark a serial number of 78214597. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Sunday, March 28, 2004. This trademark is owned by Altana Pharma. The CHROMAGEN ULTRA trademark is filed in the Pharmaceutical Products category with the following description:
Vitamins and vitamin supplements.
General Information
| Serial Number | 78214597 |
| Word Mark | CHROMAGEN ULTRA |
| Filing Date | Thursday, February 13, 2003 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Sunday, March 28, 2004 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Vitamins and vitamin supplements. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 7, 2003 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Altana Pharma |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Melville, NY 11747 |
Trademark Events
| Event Date | Event Description |
| Sunday, March 28, 2004 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, August 21, 2003 | NON-FINAL ACTION MAILED |
| Friday, August 8, 2003 | ASSIGNED TO EXAMINER |
